Obesity
Conditions
Keywords
exercise, obesity, diet, cardiometabolic
Brief summary
The goal of this clinical trial is to learn how exercise and diet quality affect the health of adolescents with obesity. The main questions it aims to answer are: * Does exercise improve cardiometabolic health in adolescents with obesity? * Does enriching the diet with fruits and vegetables improve cardiometabolic health in adolescents with obesity? * Do exercise and a fruit and vegetable diet together provide greater health benefits than either one alone in adolescents with obesity? Researchers will compare four groups to see how exercise and diet impact health: * Standard Care Group: Receives the usual care for obesity. * Exercise Group: Receives weekly exercise coaching and participates in a 12-week exercise program. * Diet Group: Receives weekly dietary coaching and eats a diet enriched with fruits and vegetables for 12 weeks. * Combined Exercise and Diet Group: Receives both exercise and dietary programs, namely weekly exercise and dietary coaching, participation in a 12-week exercise program, and daily consumption of fruits and vegetables for 12 weeks. During the 12-week study, participants will attend three study visits to: * Provide blood, stool, and urine samples. * Answer questions about health, sleep, diet, and physical activity. * Undergo body scans to measure fat, lean, and bone mass. * Complete blood vessel function and liver fat content assessments. * Assess resting exergy expenditure. * Complete fitness tests. * Wear a fitness tracker to monitor physical activity and sleep patterns.
Detailed description
The Level Up! study is a 12-week randomized controlled trial designed to investigate the independent and combined effects of exercise training and dietary enrichment on cardiometabolic health in adolescents with obesity. The study will enroll adolescents participating in an obesity treatment program. Participants will be randomly assigned to one of four groups: standard of care, exercise, dietary, or combined exercise and dietary intervention. Each participant will attend three assessment visits at baseline, week 6, and week 12 at the Arkansas Children's Nutrition Center (ACNC). The following key measurements will be conducted: * Body Composition: Dual-Energy X-ray Absorptiometry (DXA) * Metabolic Profile: Fasting blood markers, including glucose, lipid profile, and insulin resistance * Vascular Function: Brachial artery flow-mediated dilation (ultrasound) * Liver Fat Content: Elastography * Continuous Glucose Monitoring: Interstitial sensor-based glucose measurement * Resting Metabolic Rate: Indirect calorimetry * Aerobic Capacity: Cardiopulmonary exercise test (spirometry) * Muscle Strength: Dynamometry * Physical Activity & Sleep: Accelerometry * Dietary Intake: 3-day food records
Interventions
BEHAVIORALExercise Intervention
In addition to the standard of care, participants engage in exercise coaching and a 12-week exercise program, encompassing three 60-minute supervised sessions per week.
BEHAVIORALNutritional Intervention
In addition to the standard of care, participants receive dietary coaching and engage in a 12-week daily dietary program enriched with a blend of fruits and vegetables.
Sponsors
Arkansas Children's Hospital Research Institute
Study design
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
13 Years to 17 Years
Healthy volunteers
No
Inclusion criteria
* Male or female aged 13 to 17 years. * Newly enrolled in a weight management program. * Excessive weight: Class I obesity I (≥95% percentile to \< 120% of the 95th percentile), class II Obesity (≥120 to \<140% of the 95th percentile, or BMI ≥35 to \< 40 g/m2). * Less than 60 min/day of moderate to vigorous physical activity. * Fruit intake ≤ 1.5 cup equivalent per day. * Vegetable intake ≤ 1.5 cup equivalent per day. * Medical release.
Exclusion criteria
* Type 2 diabetes mellitus. * Asthma that requires daily use of inhalers to keep symptoms under control. * Asthma that requires the use of rescue inhalers (e.g., albuterol) \>2 days per week * Exercise-induced asthma. * Autism spectrum disorder (e.g., Autistic disorder, Rett disorder, Asperger disorder, childhood disintegrative disorder, pervasive developmental disorder not otherwise specified (PDD-NOS). * Epilepsy. * Cancer. * Chronic kidney disease. * Hormonal disease (e.g., hypothyroidism and growth hormone deficiency). * Autoimmune diseases (e.g., lupus, thyroiditis, juvenile idiopathic arthritis). * Bleeding disorders (e.g., hemophilia). * Chronic infections (e.g., HIV, hepatitis B, hepatitis C). * Other pre-existing medical conditions or medications as determined by the investigators to affect the outcomes of interest. * Pregnancy. * Dislike of \> 1 study product assessed at the initial visit. * Parent/child refusal to have blood drawn. * Refusal to authorize study investigators to access data from the clinical records.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Group differences in composite score of cardiometabolic health changes over time. | Baseline, 6 weeks, and 12 weeks. | The primary outcome is a composite score of cardiometabolic health status. The score is calculated as the mean of specific z-scores for the following markers: fasting triglycerides (mg/dL), total cholesterol/HDL-cholesterol ratio, HOMA2-IR, systolic blood pressure (mmHg), fat-mass-index \[whole-body fat mass (kg)/height² (m²)\], and inverse peak oxygen uptake (mL O₂/kg/min). The composite score is computed as the mean of the standardized z-scores for each marker, providing an overall measure of cardiometabolic health status. |
Secondary
| Measure | Time frame |
|---|---|
| Group differences in low-density lipoprotein (LDL) cholesterol (mg/dL) changes over time. | Baseline, 6 weeks, and 12 weeks. |
| Group differences in fow-mediated dilation (%) changes over time. | Baseline, 6 weeks, and 12 weeks. |
| Group differences in liver steatosis (dB/m) changes over time. | Baseline and 12 weeks. |
| Group differences in appendicular lean mass index changes over time. | Baseline, 6 weeks, and 12 weeks. |
Countries
United States
Contacts
CONTACTHannah Aston, MPH
CONTACTFlorêncio Sousa, Ph.D.
PRINCIPAL_INVESTIGATORElisabet Borsheim, Ph.D
Arkansas Children's Research Institute
Outcome results
None listed